Your source for important clinical and translational laboratory studies from around the world
Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.
Markman, Philadelphia, Pa.
Journal Abbreviation: Oncology
ISSN: 0030-2414 (Print)
e-ISSN: 1423-0232 (Online)
Listed in bibliographic services, including:
PubMed, MEDLINE, Web of Science, Science Citation Index, Science Citation Index Expanded, Current Contents - Clinical Medicine, Current Contents - Life Sciences, BIOSIS Previews, Google Scholar, Chemical Abstracts Service, Scopus, Embase, Pathway Studio, Academic Search, CINAHL Complete, STM Source, Health Research Premium Collection, Medical Database, Health & Medical Collection, ProQuest Central, WorldCat
Editorial Office 'Oncology'
CH–4009 Basel (Switzerland)
Tel. +41 61 306 1359
Fax +41 61 306 1434
CH-4009 Basel (Switzerland)
Fax +41 61 306 12 34
Aktualisiert am: 21.09.2017 16:40